These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19448471)

  • 41. Anticoagulant control and standardization of coagulation reagents.
    Poller L
    Med Lab Technol; 1972 Jul; 29(3):280-92. PubMed ID: 5076440
    [No Abstract]   [Full Text] [Related]  

  • 42. [Nursing care of the dialysis patient].
    Semal S
    Rev Infirm; 2009 May; (150):24-5. PubMed ID: 19537147
    [No Abstract]   [Full Text] [Related]  

  • 43. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
    Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of systemic anticoagulation in patients undergoing vascular access surgery.
    Bhomi KK; Shrestha S; Bhattachan CL
    Nepal Med Coll J; 2008 Dec; 10(4):222-4. PubMed ID: 19558057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo preclinical anticoagulation regimens after implantation of ventricular assist devices.
    Saeed D; Fukamachi K
    Artif Organs; 2009 Jul; 33(7):491-503. PubMed ID: 19566726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis.
    Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM
    Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overview of current venous thromboembolism protocols in hip reconstruction.
    Lazo-Langner A; Rodger MA
    Orthop Clin North Am; 2009 Jul; 40(3):427-36. PubMed ID: 19576411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
    Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH
    Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anticoagulation: seniors neglected?].
    Füessl HS
    MMW Fortschr Med; 2009 Apr; 151(16):28. PubMed ID: 19658291
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral anticoagulation with antiplatelet therapy after drug-eluting stent placement: adequate INR control must be demonstrated.
    Murphy P
    J Intern Med; 2009 Jun; 265(6):725; author reply 726. PubMed ID: 19493062
    [No Abstract]   [Full Text] [Related]  

  • 52. [An outpatient clinic measure and control system for anticoagulation levels, CoaguChek XS].
    Romero Guardeño A; Pérez Lucena DA
    Rev Enferm; 2009 Mar; 32(3):211-6. PubMed ID: 19462604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coagulation and anticoagulation in pulmonary arterial hypertension.
    Berger G; Azzam ZS; Hoffman R; Yigla M
    Isr Med Assoc J; 2009 Jun; 11(6):376-9. PubMed ID: 19697592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preventive and therapeutic anticoagulation in theory and practice: updates in thrombosis prevention].
    Wilke S
    Pflege Z; 2009 Jul; 62(7):412-5. PubMed ID: 19634523
    [No Abstract]   [Full Text] [Related]  

  • 55. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation.
    McLeod CJ; Gersh BJ
    Arch Intern Med; 2009 Nov; 169(21):2032-3; author reply 2033. PubMed ID: 19933968
    [No Abstract]   [Full Text] [Related]  

  • 56. Anticoagulation for the long-term treatment of VTE in patients with cancer.
    Guirguis-Blake J
    Am Fam Physician; 2009 Jul; 80(1):30. PubMed ID: 19621843
    [No Abstract]   [Full Text] [Related]  

  • 57. [Epidemiology of anticoagulation for hemodialysis patients: survey of 842 cases in seven hemodialysis centers].
    Sun XF; Xiao Q; Wang Y; Hao LR; Lin HL; Zhang ZM; Li JJ; Chen XM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):577-81. PubMed ID: 19595154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing importance of dietary data in anticoagulation treatment.
    Nielsen PB; Eriksen EH; Milthers RT; Hejlesen OK
    Stud Health Technol Inform; 2009; 150():782-6. PubMed ID: 19745418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful heparin desensitization after anaphylactic shock due to heparin.
    Altintaş ND; Aybar Türkoğlu M; Bozkurt B; Topeli Iskit A; Karakaya G; Kalyoncu AF
    Tuberk Toraks; 2009; 57(1):68-72. PubMed ID: 19533440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anticoagulation during pregnancy following an artificial heart valve replacement].
    Strecker T; Zimmermann I; Schlüter G; Feyrer R
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2116-9. PubMed ID: 19809961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.